Navigation Links
Delivering siRNA Using Adenoviral Vectors

mal systems, these viral vectors are appropriate only for transient RNA expression but are well suited for gene-therapy.

Ambion's new pSilencer adeno 1.0-CMV System combines the advantages of adenoviral vectors with an efficient siRNA expression system (see A Bit About Adenoviral Biology, at right). With pSilencer adeno, you can easily deliver an siRNA expression construct into a variety of mammalian cells and organisms. The modified CMV promoter in the vector efficiently expresses hairpin siRNAs, which elicit gene silencing through the RNAi pathway. Figures 1 and 2 show silencing of GAPDH and GFP in HeLa cells after infection with pSilencer adeno 1.0-CMV engineered to express the corresponding siRNAs. In both examples, protein levels were reduced ~90% compared to noninfected controls. The vector and promoter featured in the pSilencer adeno 1.0-CMV System were developed by Beverly Davidson and colleagues at the University of Iowa. This vector has been used by that lab to silence a number of genes in HeLa cells and adult mice (1).

Figure 1. Silencing of GAPDH Induced by pSilencer adeno. HeLa cells were infected at an MOI of 80 with adenovirus derived from the pSilencer adeno 1.0-CMV System. The virus was designed to express a GAPDH siRNA or a scrambled negative control siRNA. The media was changed 4 hours after infection and cells were analyzed after 72 hours. Immunofluorescence was performed using mouse anti-GAPDH antibody. Green: GAPDH protein. Blue: DAPI stained nuclei.

Figure 2. Silencing
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Delivering siRNAs to Difficult Cell Types
2. Custom and library siRNA for efficient gene silencing
3. Custom and library siRNA for efficient gene silencing
4. Cancer siRNA Oligo Set Version 1.0
5. Library siRNA
6. Custom siRNA Oligo Synthesis Service
7. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
8. Quantification of siRNA Silencing Efficiency Using the LightCycler System
9. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
10. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection
11. siRNA transfection optimization with the Agilent 2100 bioanalyzer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Delivering siRNA Using Adenoviral Vectors

(Date:2/26/2015)... (PRWEB) February 26, 2015 On Wednesday, ... to building a nationwide Clostridium difficile (C. diff) awareness ... diff burden study by the Centers for Disease Control ... caused almost half a million infections among Americans in ... nursing homes. , The study also estimates that ...
(Date:2/26/2015)... 26, 2015 Phosphate Therapeutics, ... the first pivotal trial of PT20 in subjects ... disease (DD-CKD), has completed as the pre-specified number ... invented by leading UK-based scientists from the Medical ... is a novel phosphate binder that is based ...
(Date:2/25/2015)... , Feb. 25, 2015 truBrain ... is featured in this week,s Power Pitch segment ... to discuss the company,s traction and growth strategy, ... the crowd funding site CircleUp. The ... that are validated by neurotechnology, while also discussing ...
(Date:2/25/2015)... HONG KONG, Feb. 25, 2015 China Cord ... the "Company"), China,s leading provider of cord blood collection, ... storage services, today announced its preliminary unaudited financial results ... fiscal 2015 ended December 31, 2014. Third ... the third quarter of fiscal 2015 increased by 10.7% ...
Breaking Biology Technology:Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 3Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 4Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 2China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 3China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 4China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 5China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 6China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 7China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 8China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 9China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 10China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 11China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 12China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 13China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 14China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 15China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 16China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 17China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 18China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 19China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 20China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 21China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 22
... HARBIN, China, Sept. 15, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical ... "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals ... results for the three months ended July 31, 2011. ... Highlights and Recent Events ...
... New York Stem Cell Summit is releasing effective today an ... the general public understand more accurately the role that autologous ... today. Approximately 1 million patients have been treated ... United States. Harvesting stem cells from adult ...
... 2011 Aperion Biologics, Inc. announced that it has ... the Company,s clinical trial of its Z-Lig™ Anterior Cruciate ... injuries of the knee. The randomized multicenter study commenced ... to provide safety and performance data in the reconstruction ...
Cached Biology Technology:China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 2China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 3China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 4China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 5China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 6China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 7China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 8New York Stem Cell Summit Issues Adult Stem Cell Fact Sheet 2Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial 2
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
(Date:2/5/2015)... , Jan. 27, 2015   Marvin ... globally deployed, innovative test solutions for military, ... delivery of its TS-323 GENASYS Test ... Company (LMSSC). GENASYS is a high-performance PXI-based ... mission-critical applications that require performance functional testing. ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... University study shows that detergents used to clean up spills ... making it more harmful. "The detergents may be the ... the dispersed oil is diluted and degraded," says Biology professor ... bioavailability and toxicity of the fuel to rainbow trout by ...
... discovered a new approach to prevent bacterial infections from ... Microbiology , Dr Quinn Parks and colleagues describe how ... defence cells to prevent Pseudomonas aeruginosa bacteria ... avoid both the body,s immune mechanisms and antibiotics. ...
... The viscosity, or ,gloopiness, of different parts of cancer ... cancer drugs, according to new images that provide fundamental ... Nature Chemistry today (15 March). ... inside cancer cells whilst they are dying as a ...
Cached Biology News:A sticky business -- how cancer cells become more 'gloopy' as they die 2
ANTI PIG LDH H4...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
... boxes are ideal for use in refrigerators, freezers, or ... Four vibrant colors allow for color coding to project, ... nitrogen drainage or promote cool air circulation. Supplied with ... 100 tubes. Box dimensions: 13 x 13 ...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
Biology Products: